Related references
Note: Only part of the references are listed.cGMP and mitochondrial K+ channels-Compartmentalized but closely connected in cardioprotection
Robert Lukowski et al.
BRITISH JOURNAL OF PHARMACOLOGY (2022)
Icariside II, a phosphodiesterase 5 inhibitor, attenuates cerebral ischaemia/reperfusion injury by inhibiting glycogen synthase kinase-3β-mediated activation of autophagy
Jianmei Gao et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Myocardial Phosphodiesterases and Their Role in cGMP Regulation
Brittany Dunkerly-Eyring et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2020)
Pervasive head-to-tail insertions of DNA templates mask desired CRISPR-Cas9-mediated genome editing events
Boris Skryabin et al.
SCIENCE ADVANCES (2020)
β3-Adrenoceptor redistribution impairs NO/cGMP/PDE2 signalling in failing cardiomyocytes
Sophie Schobesberger et al.
ELIFE (2020)
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
Paul W. Armstrong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Hypoxia signaling in human diseases and therapeutic targets
Jae W. Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Mind the gap (junction): cGMP induced by nitric oxide in cardiac myocytes originates from cardiac fibroblasts
Lukas Menges et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Cardioprotection by ischemic postconditioning and cyclic guanosine monophosphate-elevating agents involves cardiomyocyte nitric oxide-sensitive guanylyl cyclase
Sandra Frankenreiter et al.
CARDIOVASCULAR RESEARCH (2018)
New Insights Into the Role of mTOR Signaling in the Cardiovascular System
Sebastiano Sciarretta et al.
CIRCULATION RESEARCH (2018)
The role of angiotensin receptor-neprilysin inhibitors in cardiovascular disease-existing evidence, knowledge gaps, and future directions
Andrew P. Ambrosy et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
cGMP-Elevating Compounds and Ischemic Conditioning Provide Cardioprotection Against Ischemia and Reperfusion Injury via Cardiomyocyte-Specific BK Channels
Sandra Frankenreiter et al.
CIRCULATION (2017)
MOLECULAR PHYSIOLOGY OF MEMBRANE GUANYLYL CYCLASE RECEPTORS
Michaela Kuhn
PHYSIOLOGICAL REVIEWS (2016)
Modulation of Compartmentalised Cyclic Nucleotide Signalling via Local Inhibition of Phosphodiesterase Activity
Marcella Brescia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
pH sensitivity of FRET reporters based on cyan and yellow fluorescent proteins
Dahdjim-Benoit Betolngar et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2015)
Targeted disruption of PDE3B, but not PDE3A, protects murine heart from ischemia/reperfusion injury
Youn Wook Chung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Hypoxia-Inducible Factor 1 and Cardiovascular Disease
Gregg L. Semenza
ANNUAL REVIEW OF PHYSIOLOGY, VOL 76 (2014)
The vacuole versus the lysosome When size matters
Daniel J. Klionsky et al.
AUTOPHAGY (2014)
NO-independent stimulation or activation of soluble guanylyl cyclase during early reperfusion limits infarct size
Justin S. Bice et al.
CARDIOVASCULAR RESEARCH (2014)
Enhanced Expression of β3-Adrenoceptors in Cardiac Myocytes Attenuates Neurohormone-Induced Hypertrophic Remodeling Through Nitric Oxide Synthase
Catharina Belge et al.
CIRCULATION (2014)
Transgenic Mice for Real-Time Visualization of cGMP in Intact Adult Cardiomyocytes
Konrad R. Goetz et al.
CIRCULATION RESEARCH (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Protection through postconditioning or a mitochondria-targeted S-nitrosothiol is unaffected by cardiomyocyte-selective ablation of protein kinase G
Carmen Methner et al.
BASIC RESEARCH IN CARDIOLOGY (2013)
Phosphodiesterase Type 3A Regulates Basal Myocardial Contractility Through Interacting With Sarcoplasmic Reticulum Calcium ATPase Type 2a Signaling Complexes in Mouse Heart
Sanja Beca et al.
CIRCULATION RESEARCH (2013)
A Model of Hypoxia-Reoxygenation on Isolated Adult Mouse Cardiomyocytes: Characterization, Comparison With Ischemia-Reperfusion, and Application to the Cardioprotective Effect of Regular Treadmill Exercise
Lolita Portal et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2013)
Cyclic nucleotide phosphodiesterase 3A1 protects the heart against ischemia-reperfusion injury
Masayoshi Oikawa et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
Riociguat Reduces Infarct Size and Post-Infarct Heart Failure in Mouse Hearts: Insights from MRI/PET Imaging
Carmen Methner et al.
PLOS ONE (2013)
Cyclic Adenosine Monophosphate Phosphodiesterase Type 4 Protects Against Atrial Arrhythmias
Cristina E. Molina et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
An Ion-insensitive cAMP Biosensor for Long Term Quantitative Ratiometric Fluorescence Resonance Energy Transfer (FRET) Measurements under Variable Physiological Conditions
Petrus S. Salonikidis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
FRET measurements of intracellular cAMP concentrations and cAMP analog permeability in intact cells
Sebastian Boerner et al.
NATURE PROTOCOLS (2011)
Phosphodiesterases and cardiac cGMP: evolving roles and controversies
Manling Zhang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Autophagy During Cardiac Stress: Joys and Frustrations of Autophagy
Roberta A. Gottlieb et al.
ANNUAL REVIEW OF PHYSIOLOGY (2010)
Calcium-sensing receptors regulate cardiomyocyte Ca2+ signaling via the sarcoplasmic reticulum-mitochondrion interface during hypoxia/reoxygenation
Fang-hao Lu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2010)
Simultaneous Live Cell Imaging Using Dual FRET Sensors with a Single Excitation Light
Yusuke Niino et al.
PLOS ONE (2009)
Real-Time Imaging of HIF-1α Stabilization and Degradation
Ekaterina Moroz et al.
PLOS ONE (2009)
Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics
Emily J. Tsai et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Persistent cAMP-Signals Triggered by Internalized G-Protein-Coupled Receptors
Davide Calebiro et al.
PLOS BIOLOGY (2009)
Spatiotemporal dynamics of β-adrenergic cAMP signals and L-type Ca2+ channel regulation in adult rat ventricular myocytes -: Role of Phosphodiesterases
Jerome Leroy et al.
CIRCULATION RESEARCH (2008)
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2-(1H)quinolinone(cilostazol), a phosphodiesterase type 3 inhibitor, reduces infarct size via activation of mitochondrial Ca2+-Activated K+ channels in rabbit hearts
Mika Fukasawa et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Cyclic nucleotide phosphodiesterase PDE1C1 in human cardiac myocytes
Fabrice Vandeput et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Regulation of phosphodiesterase 3 and inducible cAMP early repressor in the heart
Chen Yan et al.
CIRCULATION RESEARCH (2007)
A positive feedback loop of phosphodiesterase 3 (PDE3) and inducible cAMP early repressor (ICER) leads to cardiomyocyte apoptosis
B Ding et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Functional role of phosphodiesterase 3 in cardiomyocyte apoptosis - Implication in heart failure
B Ding et al.
CIRCULATION (2005)
Nitric oxide synthase (NOS) does not contribute to simulated ischaemic preconditioning in an isolated rat cardiomyocyte model
H Strijdom et al.
CARDIOVASCULAR DRUGS AND THERAPY (2004)
Calcium homeostasis in rat cardiomyocytes during chronic hypoxia: a time course study
JM Pei et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2003)
Short-term intravenous milrinone for acute exacerbation of chronic heart failure - A randomized controlled trial
MS Cuffe et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors - The role of protein kinase A and p38 mitogen-activated protein kinase
S Sanada et al.
CIRCULATION (2001)
Changes in intracellular sodium and pH during ischaemia-reperfusion are attenuated by trimetazidine - Comparison between low- and zero-flow ischaemia
H El Banani et al.
CARDIOVASCULAR RESEARCH (2000)
Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation
PM Kang et al.
CIRCULATION RESEARCH (2000)